Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$684M |
| 2 |
Amgen
AMGN
|
+$653M |
| 3 |
Salesforce
CRM
|
+$488M |
| 4 |
Eli Lilly
LLY
|
+$452M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$437M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$815M |
| 2 |
NVIDIA
NVDA
|
+$685M |
| 3 |
TJX Companies
TJX
|
+$488M |
| 4 |
Starbucks
SBUX
|
+$373M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.92% |
| 2 | Healthcare | 18.9% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
1851
DELISTED
Exact Sciences
EXAS
| $655K | ﹤0.01% |
15,500
-328
| -2% | -$18K |
|
1852
Keros Therapeutics
KROS
$199M
| $654K | ﹤0.01% |
14,307
+4,475
| +46% | +$240K |
|
1853
Hope Bancorp
HOPE
$1.8B
| $653K | ﹤0.01% |
60,814
-590
| -1% | -$6.21K |
|
1854
Mercury Systems
MRCY
$5.97B
| $649K | ﹤0.01% |
24,025
-296
| -1% | -$8.63K |
|
1855
Mercury Insurance
MCY
$6.07B
| $646K | ﹤0.01% |
12,161
-137
| -1% | -$7.42K |
|
1856
Powell Industries
POWL
$7.32B
| $645K | ﹤0.01% |
13,500
-2,541
| -16% | -$133K |
|
1857
RxSight
RXST
$250M
| $643K | ﹤0.01% |
10,700
-154
| -1% | -$8.8K |
|
1858
Perdoceo Education
PRDO
$2.06B
| $643K | ﹤0.01% |
29,952
-329
| -1% | -$6.82K |
|
1859
Klaviyo
KVYO
$5.65B
| $642K | ﹤0.01% |
25,800
-192
| -0.7% | -$4.49K |
|
1860
Clear Secure
YOU
$5.43B
| $641K | ﹤0.01% |
34,291
-80,991
| -70% | -$1.47M |
|
1861
RELX
RELX
$66B
| $641K | ﹤0.01% |
13,975
| – | – |
|
|
CFB
1862
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $641K | ﹤0.01% |
45,729
-2,407
| -5% | -$31.1K |
|
1863
Global Net Lease
GNL
$1.86B
| $638K | ﹤0.01% |
86,788
-1,010
| -1% | -$7.32K |
|
1864
Indivior Pharmaceuticals
INDV
$4.85B
| $636K | ﹤0.01% |
40,546
-399,575
| -91% | -$7.21M |
|
1865
Alkami Technology
ALKT
$1.94B
| $631K | ﹤0.01% |
22,175
-151
| -0.7% | -$3.9K |
|
1866
Phreesia
PHR
$671M
| $628K | ﹤0.01% |
29,631
-7,470
| -20% | -$162K |
|
1867
Business First Bancshares
BFST
$1.05B
| $628K | ﹤0.01% |
28,895
-1,165
| -4% | -$24.3K |
|
1868
Recursion Pharmaceuticals
RXRX
$1.62B
| $626K | ﹤0.01% |
83,628
+21,206
| +34% | +$185K |
|
1869
Xerox
XRX
$360M
| $626K | ﹤0.01% |
53,856
-589
| -1% | -$8.55K |
|
1870
International Money Express
IMXI
$398M
| $623K | ﹤0.01% |
29,875
-2,213
| -7% | -$46.6K |
|
1871
Supernus Pharmaceuticals
SUPN
$2.77B
| $622K | ﹤0.01% |
23,254
-271
| -1% | -$7.86K |
|
1872
Arvinas
ARVN
$529M
| $621K | ﹤0.01% |
23,365
-9,064
| -28% | -$289K |
|
1873
Cannae Holdings
CNNE
$665M
| $620K | ﹤0.01% |
34,196
-337
| -1% | -$6.54K |
|
|
LSXMA
1874
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $620K | ﹤0.01% |
+28,000
| New | +$668K |
|
1875
Enact Holdings
ACT
$6.7B
| $620K | ﹤0.01% |
20,221
-153
| -0.8% | -$4.66K |
|
Similar funds
Janus Henderson Group's Q2 2024 Portfolio in Review
As of Q2 2024, Janus Henderson Group held 2,619 positions worth $187B, up 1.9% from $183B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q2 2024 filing shows 91 new, 630 increased, 1,758 reduced and 101 closed positions. Its largest new stake was UL Solutions: 2,328,210 shares worth $98.2M. The largest sale was Adobe, an estimated $815M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2024 buy was UL Solutions: 2,328,210 shares worth $98.2M.
- Janus Henderson Group added most to Broadcom in Q2 2024, an estimated $684M increase.
- Janus Henderson Group's biggest Q2 2024 reduction was Adobe, cutting an estimated $815M.
- Janus Henderson Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $157M.
- Janus Henderson Group's ten largest holdings make up 32% of its $187B portfolio in Q2 2024.
- Janus Henderson Group opened 91 new positions and closed 101 in Q2 2024.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.